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Abstract
BHK cells either untreated or infected with Semliki Forest virus have been fractionated on sucrose density gradients. Virus
infection caused an increase in density of a membrane fraction enriched in sphingomyelin (SM), cholesterol, SM synthase and
sialyltransferase activity. This increase in density was related to incorporation of viral proteins into this fraction, which is
likely to contain trans-Golgi network (TGN) membranes. In contrast, glucosylceramide synthase and galactosyltransferase
activities (markers for cis/medial and trans-Golgi respectively) underwent no density shift and alkaline phosphodiesterase, a
plasma membrane marker, was only slightly density-shifted in infected cells. When cells were incubated with NBD-ceramide
to enable them to synthesise NBD-SM and then washed with albumin to remove surface label, fluorescence in untreated cells
was concentrated in a single juxtanuclear spot but in infected cells this region of bright fluorescence was larger and extended
around the nucleus. After fractionation of these cells, NBD-SM (but only a small proportion of the NBD-ceramide) was
found to be shifted into the higher density fraction in infected cells. This work provides further evidence that SM synthase is
not mainly localised in the early Golgi cisternae as previously thought, but is associated more with a cholesterol-rich
compartment which could be the TGN. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Because sphingomyelin (SM) is the major charac-
teristic phospholipid of plasma membranes a knowl-
edge of its mode of production and incorporation is
central to our understanding of the mechanism of
plasma membrane biosynthesis. It has been widely
accepted that synthesis of this phospholipid takes
place in the early/medial Golgi apparatus [1^3] with
perhaps some subsidiary activity in plasma mem-
brane [3,4]. However, as we have previously pointed
out [5,6] there are some faults in the evidence for an
early/mid Golgi localisation and we have provided
support for the idea that the primary site of sphin-
gomyelin synthesis is not in the Golgi cisternae at all
but in a cholesterol-rich membrane which could be
plasmalemma, endosomes or TGN [7].
The data presented here extends our previous
work on subcellular fractionation of BHK ¢broblasts
[7] which showed that the density on sucrose gra-
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dients of membranes bearing SM synthase activity
was higher than the density of Golgi membranes,
was little a¡ected by brefeldin A (which had dramat-
ic e¡ects on Golgi marker enzymes) and was in-
creased by digitonin (which had no e¡ect on Golgi
markers). The present work uses a novel method for
selectively altering membrane density by infecting
BHK cells with Semliki Forest virus (SFV). The
idea for this came from the detailed morphological
studies of Gri⁄ths et al. [8] which showed that in
BHK cells infected with SFV, there was a dramatic
reduction of the Golgi cisternal membrane and an
associated accumulation of structures related to the
TGN containing quasi-crystalline arrays of SFV
spike proteins, which in many cases bound virus nu-
cleocapsids. We reasoned that either the accumula-
tion of spike proteins or the consequent binding of
nucleocapsids might potentially cause a selective in-
crease in membrane density which could be utilised
in fractionation studies. In the event, we have found
that the density of membranes rich in cholesterol and
SM (which is likely to include TGN, endosomes and
plasma membrane) is increased in cells infected with
SFV. Signi¢cantly, the density of SM synthase and
sialyltransferase is similarly increased in infected cells
but there is no e¡ect on the density of characteristic
enzyme markers of the Golgi cisternae and little ef-
fect on a marker of the plasma membrane. These
¢ndings provide further evidence that SM synthase
(at least in BHK cells) is not localised in the early/
mid Golgi cisternae and is likely to be associated
with more distal elements of the secretory pathway,
possibly the TGN.
2. Materials and methods
Unless otherwise stated, all biochemicals were pur-
chased from Sigma, Poole, Dorset, UK. [14C]acetate
and cytidine 5P monophosphate [14C]sialic acid (ace-
tylneuraminic acid), 11 GBq/mmol were from Ny-
comed-Amersham plc, Amersham, UK. N-(4,4-di-
£uoro 5,7-dimethyl-4-bora-3a,4a diaza-s-indacene-3-
pentanoyl) D-erythro-sphingosine (DMB-ceramide)
and 6((N-(7-nitrobenzo-2-oxa-1,3-diazol-4-yl) ami-
no)hexanoyl-D-erythro-sphingosine (NBD-ceramide)
were purchased from Molecular Probes, Eugene,
OR, USA. A polyclonal antibody raised in rabbits
against TGN38 of rat liver was kindly donated by Dr
George Banting, Department of Biochemistry, Uni-
versity of Bristol, UK.
2.1. Cell culture and infection with virus
BHK cells were cultured, labelled to equilibrium
(48 h) with 1 WCi/ml [14C]acetate (Nycomed-Amer-
sham), homogenised and fractionated on a sucrose
density gradients as described previously [7]. Brie£y,
cells were scraped from the dishes into bu¡ered sal-
ine, homogenised by repeated passage through a sy-
ringe needle and applied to the top of a 10 ml su-
crose 15^50% w/v sucrose gradient which was
centrifuged for 2 h at 35 000 rpm before fractionation
into 0.5 ml aliquots. Some £asks were taken when
the cells were just subcon£uent (a total of about
5U106 cells in a 75 cm2 £ask) and the radioactive
medium was removed and retained. The cells were
infected with about 106 p.f.u. of SFV (kindly do-
nated by Dr Mark Marsh, Laboratory for Molecular
Cell Biology, University College London) in serum-
free Glasgow minimal essential medium (GMEM)
for 20 min, before reculturing in the original radio-
active medium for a further 16 h. Under these con-
ditions, all the cells were infected as judged by their
rounded shape and increased density of perinuclear
vesicles but only 1^2% stained with Trypan Blue.
Homogenisation of these cells was carried out 16 h
after infection, in parallel with uninfected subcon£u-
ent control cultures. In some experiments, the culture
medium from infected cells was centrifuged at 16 000
rpm in the SS34 rotor of a Sorvall 5C centrifuge to
provide a sample of virus for gel electrophoresis. An
equivalent sediment from the medium of untreated
cells was prepared as a control.
2.2. Analysis of gradient fractions
0.3 ml aliquots of the fractions were analysed for
radioactive lipids, SM synthase and glucosylceramide
synthase activity as described previously [7], using
NBD-ceramide as substrate. After extraction of sam-
ples with 2:1 methanol/chloroform, lipids were par-
titioned into the chloroform layer of the Bligh and
Dyer phase separation [9] and a sample of the total
radioactivity was measured by liquid scintillation
counting before evaporation of the chloroform and
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analysis of the individual lipid classes by tlc. Protein
was measured by the procedure of Bradford [10].
Alkaline phosphodiesterase (APDE) and galactosyl-
transferase (enzyme markers for plasma membrane
and trans-cisternae of the Golgi apparatus respec-
tively) were assayed by standard procedures [11,12].
Sialyltransferase was assayed using lactosylceramide
as substrate in the presence of 2 mg/ml Triton CF-54
as described by Iber et al. [13] in order to maximise
the proportion of sialyltransferase IV. In this case,
0.4 ml of each fraction was diluted to 1 ml with
MOPS-bu¡ered saline (pH 7.0) and the samples
were centrifuged in Eppendorf tubes at 22 000Ug
for 1 h. The pellets were dispersed in 50 Wl of water
and the same volume of 100 mM MES bu¡er 6.0
containing 4 mg/ml Triton CF-54, 200 WM lactosyl-
ceramide, 20 mM dithiothreitol and 1 mM CMP-
[14C]acetylneuraminic acid (5000 dpm/nmol) was
added. After separation of lipids in a solvent consist-
ing of chloroform/methanol/water 70:30:5, the tlc
plate was phosphorimaged and the single spot which
coincided in mobility with GM3 was quanti¢ed. In
some experiments the ability of fractions to sialylate
asialomucoprotein (instead of lactosylceramide) was
also measured using a standard procedure [14].
Polypeptide patterns for the density gradient frac-
tions were analysed using 25 Wl samples of each frac-
tion in the PAGE procedure of Laemmli [15]. Gels
were silver stained with a standard kit (Daiichi Pure
Chemical, Tokyo, Japan) and the relative intensity of
the bands was measured using a BioRad scanning
densitometer linked to a Shimadzu computing inte-
grator. Densitometric values for viral proteins were
derived by subtraction of values for fractions from
control cells from those for the equivalent fractions
from infected samples. A major BHK cell protein in
fractions 8^10 ran close to the viral nucleocapsid
protein, which made it di⁄cult to obtain reliable
values for the relatively small amounts of nucleocap-
sid protein in fractions eight and below.
In some experiments, control and infected cells
after 16 h were incubated with 5 WM DMB-ceramide
or 10 WM NBD-ceramide in 10 ml of serum-free
medium for 1 h at 37‡C to allow them to synthesise
the corresponding SM. These cells were then washed
three times (1 min each time) with medium at 20‡C
containing 1% fat-free albumin to remove surface
£uorescent lipids (as demonstrated by confocal mi-
croscopy of parallel samples). After fractionation as
above, £uorescent spots were identi¢ed under a UV
lamp and were excised, extracted with 0.5 ml of 1:1
ethanol/water and quanti¢ed in multiwell plates us-
ing a Fluoroskan £uorimeter.
2.3. Confocal microscopy
Cells were cultured as above but on 6 cm dishes
with a thin base (Petriperm hydrophil) which allowed
direct observation of the cells in a Leica confocal
laser scanning microscope, using an inverted U40
oil immersion objective with excitation and emission
wavelengths of 488 nm and 530 nm respectively.
After removal of the medium, the cells were incu-
bated in 2 ml of serum-free GMEM containing
1 WM DMB-ceramide or 5 WM NBD-ceramide at
37‡C for 1 h. Subsequently, 1% fat-free albumin in
2 ml of serum-free GMEM was added to the samples
and incubation was continued for a further 15 min
before examination of the cells in the confocal micro-
scope.
3. Results
3.1. Sucrose density gradient subfractionation of
uninfected and infected cells
BHK cells infected with SFV and subfractionated
on a sucrose density gradient generally showed a
similar distribution of protein to untreated cells
(Fig. 1A). Besides the large peak at the top of the
gradient which corresponded to soluble protein there
was a subsidiary peak at density 1.09 (fraction 8).
However, in infected cells there was a small addition-
al protein peak in a higher density region (fractions
16^18, density 1.15). This was con¢rmed by poly-
acrylamide gel electrophoresis which demonstrated
the presence of two protein species not present in
the control gradients (Fig. 2) and which appeared
to represent the two main polypeptides of SFV, the
nucleocapsid protein (35 kDa) and the spike (E1/E2)
proteins [16,17] which usually were visualised as a
doublet (mean 53 kDa). The peak concentration of
capsid protein was in fractions 11^12 (density 1.12)
but the spike protein peaked in denser fractions
(peak 16^18, density about 1.15) (Fig. 2B). In the
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intact virus, the ratio of the protein content in E1/E2
to that in the nucleocapsid is about 5:1 (calculated
from [16,17]) but the ratio of silver staining intensity
was only 0.7:1 so that the nucleocapsid protein
stained approximately seven times as strongly as
the E1/E2 protein. This correction factor is applied
in Fig. 2B so as to give a truer idea of the relative
proportions of the two proteins in mass terms. Thus
in fractions 17^18, the mass ratio of spike protein to
capsid protein was about ¢ve which is quite similar
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to the intact virus whereas in fraction 11^12 the ratio
was about unity.
Enzyme markers for the Golgi apparatus (galacto-
syltransferase and glucosylceramide synthase) peaked
in fractions 7^8 (Fig. 1B,C) although small subsid-
iary peaks were seen in fractions 12^14. Little di¡er-
ence in this localisation was seen in infected cells
although there was a very marked decrease in total
activity of these enzymes after infection (about a 70%
decrease for galactosyltransferase and 80^90% for
glucosylceramide synthase). In contrast to the Golgi
cisternal markers, the activity of SM synthase, which
in control cells had a broad peak centring on frac-
tions 11^13 (density 1.13) was shifted to higher den-
sity (fractions 15^17, density 1.15) in infected cells
although total activity was little a¡ected (Fig. 1D).
Similarly, the peak of total lipid, cholesterol and SM
radioactivity was also shifted from fraction 11^13 in
control cells to fractions 16^17 in infected cells (Fig.
1E^G) although there was also an increase in the
amount of radioactivity near the top of the gradient.
The total activity of the plasma membrane marker
alkaline phosphodiesterase was little changed in in-
fected cells (Fig. 1H) and there was only a slight shift
Fig. 1. Separation of components of a BHK cell homogenate on a sucrose density gradient-untreated cells (open circles) compared
with SFV-infected cells (¢lled circles). Cells were incubated and fractionated into 0.5 ml aliquots on a 15^50% w/v sucrose density gra-
dient as described in Section 2 and [7]. Fraction 1 represents the top of the gradient. Determinations were made of (A) protein, (B)
galactosyltransferase activity, (C) glucosylceramide synthase activity, (D) SM synthase activity, (E) total lipid radioactivity (dpm per
20 Wl of each fraction), (F) SM radioactivity, (G) cholesterol radioactivity, (H) APDE activity and (I) sialyltransferase with lactosyl-
ceramide as substrate and (J) sialyltransferase with asialomucoprotein as substrate. The values for glucosylceramide for infected cells
have been multiplied by a factor of ten. Although infected cells generally contained about 70% of the protein of untreated cells, values
in these diagrams were normalised to the same amount of protein in each homogenate. These data were derived in a single experiment
which was representative of four other experiments carried out under the same conditions.
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towards higher density, although there was more ac-
tivity near the top of the gradient than in the unin-
fected cells. Sialyltransferase activity using lactosyl-
ceramide as substrate showed a peak about fraction
12 in control cells (Fig. 1I) but in virus-infected cells,
the peak was shifted to fractions 15^18 (results from
three experiments). Similar results were obtained
when protein-sialylating activity was measured using
asialomucoprotein as substrate but in this case there
was more activity in the region of the gradient cor-
responding to the Golgi enzyme markers and this
lighter peak was still evident in infected cells (Fig.
1J).
3.2. Confocal microscopy and fractionation of cells
labelled with £uorescent ceramides
When uninfected cells were incubated with NBD-
ceramide or DMB-ceramide for 1 h and washed in
the presence of albumin to remove surface label,
most of the £uorescence remaining was in a small
juxtanuclear region (Fig. 3A) as described previously
and then identi¢ed with the Golgi apparatus [18,19].
The juxtanuclear £uorescence accounted for about
5% of the total cell area but up to 40% of the total
£uorescence. After fractionation of the cells the dis-
tribution of NBD-SM resembled that of cholesterol,
SM and alkaline phosphodiesterase with a peak in
fractions 12^14, although a minor peak was often
observed in fractions 7^8 where the Golgi marker
enzymes sedimented (Fig. 4a). In virus-infected cells,
the juxtanuclear £uorescence was increased and
greatly extended around the nucleus compared with
uninfected cells (Fig. 3B). On a sucrose density gra-
dient the peak of NBD-SM appeared in fractions 15^
17 and there was no peak in the Golgi region around
fractions 7^8 (Fig. 4a). The distribution of NBD-ce-
ramide in control and infected cells was quite dissim-
ilar to that of NBD-SM with most of it appearing in
the pellet (fraction 23) (Fig. 4b). Similar results were
obtained using DMB-ceramide (not shown).
4. Discussion
4.1. The origin of the membrane density shift induced
by SFV infection
Although it is clear from the results presented here
that infection with SFV caused a marked increase in
the density of membranes enriched in SM synthase,
cholesterol and SM the precise mechanism of this
e¡ect has not been established. Originally we postu-
lated that an increase in density of the TGN might
be caused by the huge accumulation of spike proteins
in TGN and/or by the consequent binding of nucle-
ocapsids to the cytosolic domain of the spike pro-
teins [8]. This idea seems to be supported by the
observation that the ratio of spike protein to capsid
protein in fractions 16^18 is about the same as in the
intact virus (Fig. 2B), consistent with the binding of
a maximum number of nucleocapsids to the array of
Fig. 2. Distribution on a sucrose density gradient of polypepti-
des derived from homogenates of untreated and SFV-infected
BHK cells. Samples of the fractions from the experiment shown
in Fig. 1 were analysed by PAGE and silver-stained as de-
scribed in Section 2. The fraction numbers in (A) are as indi-
cated and represent paired control (C) and infected (V) samples.
One lane contains virus isolated from the culture supernatant
(SFV) and another contains standard molecular weight markers
(M) together with the corresponding molecular weights ex-
pressed in kDa. Similar results were obtained with four other
samples of cells. The results of densitometric quanti¢cation of
the viral polypeptides in gradient fractions from the infected
samples are shown in (B) where open circles represent nucleo-
capsid protein and ¢lled circles represent the spike E1/E2 pro-
teins. These results represent the means of values obtained from
four separate experiments using di¡erent samples of cells. Error
bars have been omitted for clarity.
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spike proteins. The bulk of the capsid protein in the
cells, present in the well-de¢ned peak in fractions 11^
12, probably corresponds to unbound nucleocapsids
which have not sedimented to equilibrium density
[20].
The density of fractions 16^18 is close to the equi-
librium density for intact virus, which bands at about
40% w/v sucrose (density 1.15) [17] but there is little
reason to think that there would be any intact virus
in cells which had been fractionated after washing
several times. Certainly, intact virus could not con-
tribute to any SM synthase activity since none was
measurable in a preparation of intact virus (unpub-
lished data). Another possibility is that under the
conditions used here, su⁄cient virus is endocytosed
to increase the e¡ective density of endocytic vesicles
from their original value of 1.12 [20]. However the
results of Gri⁄ths et al. [8] show that most of the
intracellular nucleocapsids are attached to the cyto-
plasmic face of membranes rather than being associ-
ated with the luminal surface as would be expected
for endosomally derived virus. Nevertheless, it seems
likely that the dense fraction also contains elements
of plasma membrane which during homogenisation,
have vesiculated with su⁄cient nucleocapsid attached
to the cytoplasmic face to increase their density to
1.15. Indeed, considering the relatively small amount
of TGN compared with plasma membrane even in
infected cells [8], such nucleocapsid-loaded plasma
membrane vesicles could account for a considerable
proportion of the density-shifted material, particu-
larly in terms of cholesterol and SM which are nor-
mally regarded as markers of plasma membrane.
Thus the dense fraction probably includes a TGN
which under the in£uence of viral infection, has
been shown to proliferate at the expense of both
the Golgi cisternae and the plasma membrane [8],
but is also likely to include plasma membrane con-
stituents, although curiously, the classical plasma
membrane marker APDE shows very little shift in
density in infected cells (Fig. 1H). TGN membranes
from uninfected BHK cells are di⁄cult to resolve
from plasma membranes on sucrose density gradients
although they do separate from the main Golgi cis-
ternal markers [20] and of course, it is entirely ex-
pected that as proximal donor of membrane to the
cell surface the TGN should resemble plasma mem-
brane in lipid composition i.e. it should be relatively
rich in SM and cholesterol. In contrast to these re-
sults with ¢broblasts, Lammert et al. have shown
recently [21] that the TGN marker protein TGN38
is also concentrated in a light rat liver subfraction
which does not separate from the trans-Golgi
marker, galactosyltransferase. It is possible that be-
cause of the particular function of the liver in secret-
ing lipoproteins, the TGN with its cargo of lumenal
lipoprotein is less dense than the TGN of less speci-
alised cells.
Although we had hoped to similarly de¢ne the
distribution of the TGN of BHK ¢broblasts using
an antiserum to TGN38 the result was disappointing
because with BHK cells, the antiserum to the rat
Fig. 3. Confocal microscope images of untreated (A) and infected (B) cells labelled with DMB-ceramide. Confocal microscopy was
carried out as described in Section 2. Closely similar results were obtained on two subsequent samples of cells, one of which was la-
belled with NBD-ceramide instead of DMB-ceramide. Bar represents 10 Wm.
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protein did not detect a band equivalent to the ma-
ture TGN38 in rat liver which has an apparent mo-
lecular weight about 90 kDa [21,22]. Instead it rec-
ognised a doublet at 61^63 kDa (unpublished
observations) which has been observed previously
[22] and may correspond to partly-processed rat
TGN38 (G. Banting, personal communication).
This may arise from a species di¡erence between
hamsters and rats.
4.2. Subcellular localisation of SM synthesis in
normal and infected cells
As we have described previously using fractions of
BHK cells subjected to various treatments [7], the
distribution of SM synthase activity on sucrose den-
sity gradients (Fig. 1D) did not coincide with the
distribution of Golgi marker enzymes, but was closer
to that of the plasma membrane markers SM, cho-
lesterol and alkaline phosphodiesterase (Fig. 1F^H).
However, as noted previously [7], SM synthase activ-
ity had a broad distribution and a signi¢cant minor
fraction did sediment with Golgi markers (Fig. 1D).
Similarly, in virus-infected cells where there was an
increase in density of membrane fractions rich in SM
and cholesterol (Fig. 1F,G) there was a correspond-
ing increase in the density of SM synthase activity
(Fig. 1D) but no e¡ect on the density of galactosyl-
transferase (a trans-Golgi marker) and glucosylcer-
amide synthase (a marker of the early/medial Golgi)
(Fig. 1B,C) [23]. This is clear additional evidence that
SM synthase is localised to a subcellular fraction
distinct from the main Golgi cisternae, probably ei-
ther the TGN, plasma membrane or some other cho-
lesterol-rich membrane.
The massive shift of membrane material out of the
Golgi cisternae and into the TGN induced by SFV
infection [8] could potentially cause movement into
the TGN of proteins normally resident in the Golgi
cisternae. However, this seems unlikely to explain the
appearance of SM synthase in TGN-enriched frac-
tions since characteristic Golgi enzymes such as gal-
actosyltransferase and glucosylceramide synthase are
not shifted into a denser fraction under the same
conditions. Nevertheless, we cannot exclude the pos-
sibility that a minor ‘Golgi-associated’ fraction of
SM synthase does undergo such a shift into the
TGN.
The results were slightly complicated by the obser-
vation that the total activity of galactosyltransferase
and glucosylceramide synthase was greatly dimin-
ished in infected cells after 16 h (Fig. 1B,C) but
this is unsurprising because it has been established
previously that synthesis of many host cell proteins is
inhibited in cells infected by enveloped virus [24] and
there is evidence that the amount of Golgi cisternal
membrane in SFV-infected cells 8 h after infection is
reduced to about 25% of that in control cells [8]. In
contrast to the large reduction in activity of Golgi
cisternal enzymes, SM synthase (Fig. 1D), APDE
(Fig. 1H) and sialyltransferase (Fig. 1I,J) showed
much the same total activity in infected cells as in
Fig. 4. Distribution of £uorescent SM (a) and ceramide (b) in a
sucrose density gradient separation of homogenates of normal
and SFV-infected cells pretreated with NBD-ceramide. Samples
of normal and SFV-infected cells were incubated with NBD-ce-
ramide before homogenisation and fractionation on a 15^50%
w/v sucrose density gradient as described in Section 2. Lipids
were extracted and separated and £uorescent spots were quanti-
¢ed also as described in Section 2. Similar results were obtained
with three other samples of cells. Filled circles refer to infected
cells ; open circles represent control cells not treated with virus.
BBAMCR 14485 29-6-99
D. Allan, M.J.M. Obradors / Biochimica et Biophysica Acta 1450 (1999) 277^287284
uninfected controls and this again suggests that SM
synthase and sialyltransferase are not part of the
Golgi cisternal complex which appears to be greatly
diminished in infected cells.
Besides causing an increase in density of fractions
rich in cholesterol, SM and SM synthase, viral infec-
tion also promoted an increase in the amount of
cholesterol, SM and APDE near the top of the gra-
dient (fractions 1^4). These fractions contain lysoso-
mal activities [7] and appear to represent the ‘£oating
lysosomes’ enriched in lysobisphosphatidic acid de-
scribed originally by Brotherus and Renkonen [25,26]
and which probably correspond to late endosomes
[27]. The presence of plasma membrane components
such as SM, cholesterol and APDE in late endo-
somes is not unexpected as a consequence of endo-
cytic activity but it is signi¢cant that very little Golgi
marker enzyme activity or SM synthase activity was
ever seen in this fraction in untreated or infected
cells. This could indicate that SM synthase is not a
characteristic enzyme of plasma membrane, although
equally it could mean that the activity is destroyed
under the acidic conditions inside late endosomes.
Sialyltransferase measured with lactosylceramide
as substrate showed a gradient distribution similar
to that of SM synthase, with the peak activity of
untreated cells in the middle of the gradient, where
plasma membrane sedimented (Fig. 1I). As with SM
synthase there was also a minor peak of activity in
the Golgi region and this Golgi peak of activity was
more prominent when asialomucoprotein was used
as substrate instead of lactosylceramide (Fig. 1J).
De Curtis et al. [20] found no separation between
markers for TGN and plasma membrane in fractio-
nated BHK cells but this contrasts with the situation
in rat liver where a TGN marker (TGN38) sedi-
mented in a less dense fraction than plasma mem-
brane [21]. The reason for this discrepancy is un-
known but it could be related to the fact that the
lumen of liver TGN is likely to contain large
amounts of the characteristic secretory lipoprotein
which could render this organelle less dense.
Sialyltransferase distribution also resembled that
of SM synthase in virus-infected BHK cells, showing
a shift to higher density (Fig. 1I,J) although with
asialomucoprotein as substrate there was a signi¢-
cant peak in the Golgi region which did not appear
to shift in density. In neuronal cells, sialyltransferase
activity is necessary for the synthesis of GM3 in the
Golgi cisternae and also at a more distal site (prob-
ably the TGN) for the synthesis of more complex
gangliosides (e.g. GM1) [28] and for protein sialyla-
tion. Part of this distal activity can also utilise lacto-
sylceramide as substrate [13] and is thus potentially
capable of generating GM3 in the TGN. In BHK
cells, as with many non-neuronal tissues, GM3 is
the major ganglioside and it appears from the data
presented here that sialyltransferase is associated not
just with the Golgi stack, but probably also with
elements of the TGN. Possibly the Golgi activity,
which is seen more prominently with asialomucopro-
tein as substrate, corresponds to sialotransferase I
whereas the TGN activity corresponds to sialotrans-
ferase IV. The assay conditions with lactosylceramide
as substrate were designed to inhibit sialyltransferase
I while preserving sialyltransferase IV and this could
explain the di¡erence between the results with lacto-
sylceramide as substrate (Fig. 1I) and those with
asialomucoprotein as substrate (Fig. 1J). Such a lo-
calisation would be consistent with the results of
Lannert et al. [21] who showed that lactosylceramide
(the precursor of GM3) is synthesised in the same rat
liver fractions as TGN38.
4.3. Morphological evidence for localisation of SM
synthase
The apparent similarity in the distributions of SM
synthase and sialyltransferase IV in BHK cell frac-
tions suggests that SM synthase is also localised in
the TGN although the cell fractionation data does
not exclude the possibility that SM synthase is in
plasma membrane. However, it is di⁄cult to recon-
cile the present data with previous work [1,2] which
shows that the distribution of SM synthase in rat
liver is similar to that of N-acetylglucosaminylphos-
photransferase which is regarded as an enzyme
marker of the early Golgi apparatus. Nevertheless,
other evidence argues in favour of a localisation of
SM synthase in the TGN of BHK cells rather than
the early Golgi or plasma membrane. Thus histo-
chemical localisation of £uorescence after treatment
of cells with DMB-ceramide reveals stain not in the
cis/medial cisternae but only in the most distal cister-
na of the Golgi together with the connected tubular
system [19,29] which together have been de¢ned as
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the TGN by Gri⁄ths and coworkers [8]. Elegant
con¢rmation was obtained by Johnson and co-
workers who showed that the £uorescence of NBD-
ceramide colocalised with TGN38, a resident protein
of the TGN [30]. Now this information must be in-
terpreted in the light of Pu«tz and Schwartzman’s ob-
servation that juxtanuclear ‘Golgi’ staining with £u-
orescent ceramide may be due not to the ceramide
itself but to a metabolite derived from the ceramide,
most likely the corresponding SM [31]. Similar ob-
servations were made by Pagano and his co-workers
[32] who showed that in well-¢xed cells, under con-
ditions where metabolism of ceramide was prevented,
there was no speci¢c accumulation of £uorescence in
the juxtanuclear region. In contrast, accumulation of
juxtanuclear £uorescence was observed when the ¢x-
ative was glutaraldehyde which is well-known to pre-
serve some enzyme activities (e.g. thiamine pyrophos-
phatase which was used as a Golgi marker in these
experiments [32]) and may also allow SM synthase to
function. Although it has been often assumed that
£uorescent ceramide itself accumulates in the Golgi,
no satisfactory rationale for this surprising localisa-
tion has ever been put forward. The evidence sum-
marised here suggests that it is not £uorescent ceram-
ide which accumulates but a metabolite which is
most likely to be the corresponding SM. The simplest
explanation for this conclusion is that £uorescent
ceramide is rapidly converted into SM in the TGN
but the SM is only transferred out of the TGN by a
relatively slow vesicular transport process. Conse-
quently £uorescent SM accumulates in the TGN.
The results presented here for cells which have
been labelled with NBD-ceramide are consistent
with the above hypothesis. Thus, the £uorescent re-
gion close to the nucleus (Fig. 3A) which has often
been identi¢ed with the Golgi apparatus [18] is
greatly expanded in the infected cells (Fig. 3B). Since
Gri⁄ths et al. [8] showed that SFV infection causes
an expansion of the TGN and a large diminution in
the size of the Golgi stack, the enlarged area of £uo-
rescence in infected cells (and by implication, the
restricted area of £uorescence in untreated cells) is
more likely to represent the TGN than the Golgi
cisternae. After subcellular fractionation, NBD-SM
but not NBD-ceramide is concentrated in fractions
12^14 in control cells but is shifted into the higher
density region (fractions 15^17) in infected cells (Fig.
4). This behaviour is in marked contrast to that of
the enzyme markers of the Golgi cisternae (Fig.
1B,C) and provides further evidence that the speci¢c
staining of the juxtanuclear region is due to the ac-
cumulation of NBD-SM £uorescence in the TGN
rather than accumulation of NBD-ceramide in the
Golgi stack.
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